Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006.
Br J Cancer
; 119(6): 670-674, 2018 09.
Article
in En
| MEDLINE
| ID: mdl-30202085
Full text:
1
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents, Immunological
/
Melanoma
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2018
Type:
Article
Affiliation country:
United States